| Net loss | |
| Change in fair market value adjustment of convertible debentures | |
| Depreciation | 147.29K |
| Amortization | 102.56K |
| Share-based compensation | 3.84M |
| Accretion of capitalized finance costs | 99.72K |
| Accretion of debt discounts | 3.19M |
| Accretion of royalty liability | |
| Derivative (gain) loss | -1.42M |
| Impairment of intangible assets | |
| Issuance of common stock shares for services | |
| Issuance of common stock warrants for finance costs | 0 |
| Issuance of common stock shares for interest expense | |
| Gain on settlement | 0 |
| Cash proceeds from settlement | |
| Accounts receivable | 1.1M |
| Inventories | 132.04K |
| Unbilled receivables | -238.63K |
| Prepaid expenses and other current assets | -49.24K |
| Other assets | 75.08K |
| Accounts payable | 465.85K |
| Accrued expenses | 4.21M |
| Unearned revenues | 394.17K |
| Customer deposits | -115.55K |
| Net cash flows from operating activities before reorganization items | |
| Gain on reorganization plan | -5.69M |
| Decrease in accrued professional fees | |
| Decrease in provision for indemnity agreement | |
| Total reorganization items | |
| Net cash flows from operating activities | -6.31M |
| Acquisition of property, plant and equipment | -98K |
| Net cash flows from investing activities | 5.4M |
| Proceeds from long-term convertible notes | |
| Payments of long-term debt | |
| Payment of deferred financing costs | 0 |
| Proceeds from the exercise of stock options | 35.51K |
| Proceeds from notes payable, related party | 3.5M |
| Payments made (to) from related party, net | -11.71K |
| Net cash flows from financing activities | 616.44K |
| Net change in cash and cash equivalents | -291.37K |
| Cash and cash equivalents at beginning of period | 420.54K |
| Cash and cash equivalents at end of period | 129.17K |
| Interest | 572.18K |
| Income taxes | |
| Reclassification of derivative to equity | |
| Cumulative effect of change in accounting principal | |
| Accentia common stock issued on effective date upon the conversion of debt | |
| Accentia common stock issued for services | |
| Accentia common stock issued upon the conversion of promissory notes | |
| Accentia common stock issued in resolution of disputed claims | |
| Accentia owned Biovest shares tendered in payment of Accentia debt | |
| Biovest common stock issued on effective date upon the conversion of debt | |
| Reclassification of Biovest beneficial conversion feature to equity | |
| Reclassification of Accentia beneficial conversion feature to equity | |
| Biovest shares for interest | |
| Biovest shares issued upon the conversion of Biovest debt | |